Trinity Biotech (TRIB) Change in Cash (2009 - 2024)

Trinity Biotech (TRIB) has reported Change in Cash for 16 consecutive years, with $2.4 million the latest figure, recorded in Q4 2024.

• Quarterly Change in Cash rose 200.29% year-over-year to $2.4 million in Q4 2024, while the trailing twelve-month figure through Dec 2024 was -$8.7 million (up 38.52% YoY) and the FY2025 annual result came in at -$100000.0, down 105.88% from the prior year.
• Change in Cash grew to $2.4 million in Q4 2024 per TRIB's latest filing, from -$2.4 million in the prior quarter.
• Over the last five years, Change in Cash for TRIB reached as high as $32.3 million in Q1 2021 and fell as low as -$8.0 million in Q3 2023.
• A 5-year average of $8.8 million and a median of $2.4 million in 2024 frame the typical range for Change in Cash.
• Annual changes were most pronounced in 2023 — Change in Cash sank 240.68% — and 2024, when it jumped 200.29%.
• Year by year, Change in Cash stood at $27.3 million in 2020, then slumped by 106.34% to -$1.7 million in 2021, then soared by 59.12% to -$708000.0 in 2022, then plunged by 240.68% to -$2.4 million in 2023, then soared by 200.29% to $2.4 million in 2024.
• According to Business Quant data, Change in Cash over the past three periods registered $2.4 million, -$2.4 million, and -$8.0 million for Q4 2024, Q4 2023, and Q3 2023 respectively.